JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 33 No. 7 1269-1277
© 1992 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murray, G.
Right arrow Articles by Rockett, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murray, G.
Right arrow Articles by Rockett, J.

Metabolic Cardiac Imaging in Severe Coronary Disease: Assessment of Viability with Iodine-123-Iodophenylpentadecanoic Acid and Multicrystal Gamma Camera, and Correlation with Biopsy

Gary Murray, Nikolaus Schad, William Ladd, David Allie, Roger Vander Zwagg, Phillip Avet and John Rockett

Cardiovascular Institute of the South, Houma, Louisiana
Institute of Radiological and Imaging Sciences, University of Siena, Italy
Health Services Research and Nuclear Medicine Department, Baptist Memorial Hospital, Memphis, Tennessee
Terrebonne General Medical Center, Houma, Louisiana

Correspondence: For reprints contact: Gary L. Murray, MD, Suite 210, 5220 Park Ave., Memphis, TN 38119.

ABSTRACT

Fifteen patients with coronary disease and resting left ventricular ejection fractions of ≤0.35 underwent resting metabolic cardiac imaging utilizing 1 mCi [123I]iodophenylpentadecanoic acid (IPPA) intravenously and a multicrystal gamma camera. Parametric images of regional rates of IPPA clearance and accumulation were generated. Forty-two vascular territories (22 infarcted) were evaluated by metabolic imaging as well as transmural myocardial biopsy. Despite resting akinesis or dyskinesis in 20/22 (91%) infarcted territories, 16/22 (73%) of these territories were metabolically viable. Transmural myocardial biopsies in all patients (43 sites, 42 vascular territories) during coronary bypass surgery confirmed IPPA results in 39/43 patients (91%). When compared to biopsy, scan sensitivity for viability was 33/36 (92%) with a specificity of 6/7 (86%). Eighty percent of bypassed, infarcted but IPPA viable segments demonstrated improved regional systolic wall motion postoperatively as assessed by exercise radionuclide angiography. We conclude resting IPPA imaging identifies viable myocardium, thereby providing a safe, cost-effective technique for myocardial viability assessment.




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
G. L. Murray, N. Schad, A. J. Bush, and G. L. Murray
Viability After Myocardial Infarction: Can It Be Assessed Within Five Minutes by Low-Dose Dynamic Iodine-123-Iodophenylpentadecanoic Acid Imaging with a Multicrystal Gamma Camera?
Angiology, April 1, 1997; 48(4): 309 - 319.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1992 by the Society of Nuclear Medicine.